Table 2 Different published studies used radiotherapy for PPTID
Authors | Total Number of patients in the study | Total number of patients with radiotherapy | Number of patients with Craniospinal radiotherapy | Dose | Stereotactic | Chemotherapy | Outcome |
|---|---|---|---|---|---|---|---|
Schild et al. (1993) | 4 | 4 | Not clear | 45–64.8 Gy | Not clear | Not clear | No specific data |
Fauchon et al. (2000) | 26 patients were classified as Grade 2 and Grade 3 not PPID | 14 | 12 | Neuroaxis Dose average 31 Gy (range 10–38 Gy) | Yes | Yes 6 patients Various regime | 5 years survival 74 % and 39 % for Grade 2 and 3 respectively |
Lutterbach et al. (2002) | 37 specimens were retrospectively analysed to classify them as PPTIDs | Not clear | Not clear | Range 20–75 Gy Median 54 Gy | Yes | Yes Cis/Vin, Cis/Eto, Cap/Ifo, VIP16/Cis, Vip16/D/F, MTX it, LO/CIS/VI | Median overall survival 165 months |
Stoiber et al. (2010) | 1 | 1 | 0 | 54 Gy/30 f L | No | No | Time to progression 84 months |
Tsubasa et al. (2014) | 5 | 5 | 2 | L 54 Gy, CSI 36 Gy WVI 18 | No | Yes 4 patients VNCI | Medial overall survival 94.1 months |
Ito et al. (2014) | 6 | 6 | 4 | 22 Gy/10 f L 54.4 Gy/28 f WB + L+WS 50 Gy/25 f EL+L | Yes | Yes 3 patients ACNU,VDS,VCR,ICE | Median event free survival 39 months |